speb/financial-data huggingface dataset:
VREX balance_sheet (annual, 2024-09-30) — Other Current Assets: 26900000.00
VREX balance_sheet (annual, 2024-09-30) — Other Current Borrowings: 46300000.00
VREX balance_sheet (annual, 2024-09-30) — Other Current Liabilities: 10500000.00
VREX balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 10500000.00
VREX balance_sheet (annual, 2024-09-30) — Other Equity Adjustments: -2900000.00
VREX income_statement (annual, 2024-09-30) — Other Income Expense: -4200000.00
VREX balance_sheet (annual, 2024-09-30) — Other Intangible Assets: 16100000.00
VREX cash_flow (annual, 2024-09-30) — Other Non Cash Items: 2200000.00
VREX balance_sheet (annual, 2024-09-30) — Other Non Current Assets: 46800000.00
VREX balance_sheet (annual, 2024-09-30) — Other Non Current Liabilities: 31900000.00
VREX income_statement (annual, 2024-09-30) — Other Non Operating Income Expenses: -3000000.00
VREX balance_sheet (annual, 2024-09-30) — Other Properties: 28300000.00
VREX balance_sheet (annual, 2024-09-30) — Other Short Term Investments: 31800000.00
VREX balance_sheet (annual, 2024-09-30) — Payables: 67200000.00
VREX balance_sheet (annual, 2024-09-30) — Payables And Accrued Expenses: 97200000.00
VREX balance_sheet (annual, 2024-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 30000000.00
VREX balance_sheet (quarterly, 2024-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 30000000.00
VREX balance_sheet (annual, 2024-09-30) — Preferred Stock: 0.00
VREX income_statement (annual, 2024-09-30) — Pretax Income: 5000000.00
VREX cash_flow (annual, 2024-09-30) — Proceeds From Stock Option Exercised: 3800000.00
VREX cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 1800000.00
VREX balance_sheet (annual, 2024-09-30) — Properties: 0.00
VREX balance_sheet (quarterly, 2024-09-30) — Properties: 0.00
VREX cash_flow (annual, 2024-09-30) — Purchase Of Business: 0.00
VREX cash_flow (annual, 2024-09-30) — Purchase Of Investment: -61000000.00
VREX cash_flow (annual, 2024-09-30) — Purchase Of PPE: -26900000.00
VREX balance_sheet (annual, 2024-09-30) — Raw Materials: 214500000.00
VREX balance_sheet (annual, 2024-09-30) — Receivables: 157700000.00
VREX income_statement (annual, 2024-09-30) — Reconciled Cost Of Revenue: 554100000.00
VREX income_statement (annual, 2024-09-30) — Reconciled Depreciation: 31100000.00
VREX cash_flow (annual, 2024-09-30) — Repayment Of Debt: -1600000.00
VREX income_statement (annual, 2024-09-30) — Research And Development: 87000000.00
VREX income_statement (annual, 2024-09-30) — Restructuring And Mergern Acquisition: -2100000.00
VREX balance_sheet (annual, 2024-09-30) — Retained Earnings: 64400000.00
VREX cash_flow (annual, 2024-09-30) — Sale Of Business: 900000.00
VREX cash_flow (quarterly, 2024-09-30) — Sale Of Business: 0.00
VREX cash_flow (annual, 2024-09-30) — Sale Of Investment: 60600000.00
VREX income_statement (annual, 2024-09-30) — Selling General And Administration: 137800000.00
VREX balance_sheet (annual, 2024-09-30) — Share Issued: 41094179.00
VREX income_statement (annual, 2024-09-30) — Special Income Charges: 2100000.00
VREX cash_flow (annual, 2024-09-30) — Stock Based Compensation: 15300000.00
VREX balance_sheet (annual, 2024-09-30) — Stockholders Equity: 529100000.00
VREX balance_sheet (annual, 2024-09-30) — Tangible Book Value: 222000000.00
VREX income_statement (annual, 2024-09-30) — Tax Effect Of Unusual Items: -42000.00
VREX income_statement (annual, 2024-09-30) — Tax Provision: 53300000.00
VREX income_statement (annual, 2024-09-30) — Tax Rate For Calcs: 0.21
VREX balance_sheet (annual, 2024-09-30) — Total Assets: 1213600000.00
VREX balance_sheet (annual, 2024-09-30) — Total Capitalization: 926200000.00
VREX balance_sheet (annual, 2024-09-30) — Total Debt: 470400000.00
VREX balance_sheet (annual, 2024-09-30) — Total Equity Gross Minority Interest: 543200000.00
VREX income_statement (annual, 2024-09-30) — Total Expenses: 778900000.00
VREX balance_sheet (annual, 2024-09-30) — Total Liabilities Net Minority Interest: 670400000.00
VREX balance_sheet (annual, 2024-09-30) — Total Non Current Assets: 563700000.00
VREX balance_sheet (annual, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 474500000.00
VREX income_statement (annual, 2024-09-30) — Total Operating Income As Reported: 32100000.00
VREX income_statement (annual, 2024-09-30) — Total Other Finance Cost: 3400000.00
VREX balance_sheet (annual, 2024-09-30) — Total Tax Payable: 8100000.00
VREX balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 8100000.00
VREX income_statement (annual, 2024-09-30) — Total Unusual Items: -200000.00
VREX income_statement (annual, 2024-09-30) — Total Unusual Items Excluding Goodwill: -200000.00
VREX balance_sheet (annual, 2024-09-30) — Tradeand Other Payables Non Current: 4000000.00
VREX balance_sheet (quarterly, 2024-09-30) — Tradeand Other Payables Non Current: 4000000.00
VREX balance_sheet (annual, 2024-09-30) — Work In Process: 16200000.00
VREX balance_sheet (annual, 2024-09-30) — Working Capital: 454000000.00
VREX income_statement (annual, 2024-09-30) — Write Off: 0.00
VREX cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: 1500000.00
VREX cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -700000.00
VREX cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
VREX cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
VREX income_statement (quarterly, 2025-03-31) — +Operating Expense: 54600000.00
VREX income_statement (quarterly, 2025-03-31) — +Total Revenue: 212900000.00
VREX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 70800000.00
VREX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 145700000.00
VREX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 474700000.00
VREX balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1300000.00
VREX cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 1000000.00
VREX cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 1000000.00
VREX cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 1100000.00
VREX income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: 1600000.00
VREX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 41400000.00
VREX income_statement (quarterly, 2025-03-31) — Basic EPS: 0.17
VREX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 301800000.00
VREX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -6800000.00
VREX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 23500000.00
VREX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 400000.00
VREX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 205100000.00
VREX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 223000000.00
VREX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -700000.00
VREX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 14700000.00
VREX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 16600000.00
VREX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 4800000.00
VREX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 4700000.00
VREX cash_flow (quarterly, 2025-03-31) — Change In Inventory: -5500000.00
VREX cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 1300000.00
VREX cash_flow (quarterly, 2025-03-31) — Change In Payable: 4800000.00
VREX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 9500000.00
VREX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -2200000.00
VREX cash_flow (quarterly, 2025-03-31) — Change In Receivables: -7900000.00
VREX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -4800000.00
VREX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -7900000.00
VREX cash_flow (quarterly, 2025-03-31) — Changes In Cash: 30600000.00
VREX balance_sheet (quarterly, 2025-03-31) — Common Stock: 400000.00
VREX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 549700000.00
VREX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 136200000.00
VREX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 83000000.00
VREX balance_sheet (quarterly, 2025-03-31) — Current Assets: 683800000.00
VREX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 3900000.00
VREX balance_sheet (quarterly, 2025-03-31) — Current Debt: 1400000.00
VREX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 5300000.00
VREX balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 9700000.00
VREX balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 9700000.00
VREX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 168800000.00
VREX cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 100000.00
VREX cash_flow (quarterly, 2025-03-31) — Deferred Tax: 100000.00
VREX cash_flow (quarterly, 2025-03-31) — Depreciation: 5600000.00
VREX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 6600000.00
VREX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 6600000.00
VREX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 51200000.00
VREX income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.17
VREX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 8500000.00
VREX income_statement (quarterly, 2025-03-31) — EBIT: 20200000.00
VREX income_statement (quarterly, 2025-03-31) — EBITDA: 26800000.00
VREX cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 1400000.00
VREX cash_flow (quarterly, 2025-03-31) — End Cash Position: 332200000.00
VREX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -700000.00
VREX balance_sheet (quarterly, 2025-03-31) — Finished Goods: 34300000.00
VREX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 9800000.00
VREX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -2400000.00
VREX balance_sheet (quarterly, 2025-03-31) — Goodwill: 290300000.00
VREX balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 305600000.00
VREX balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 147000000.00
VREX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 177600000.00
VREX income_statement (quarterly, 2025-03-31) — Gross Profit: 76700000.00
VREX cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 7800000.00
VREX income_statement (quarterly, 2025-03-31) — Interest Expense: 9400000.00
VREX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 9400000.00
VREX income_statement (quarterly, 2025-03-31) — Interest Income: 2900000.00
VREX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 2900000.00
VREX cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 200000.00
VREX balance_sheet (quarterly, 2025-03-31) — Inventory: 284700000.00
VREX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1116900000.00
VREX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 14700000.00
VREX balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 23200000.00
VREX cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
VREX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 19600000.00
VREX balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 565800000.00
VREX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 585400000.00
VREX cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
VREX cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -400000.00
VREX balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 23200000.00
VREX balance_sheet (quarterly, 2025-03-31) — Minority Interest: 14200000.00
VREX income_statement (quarterly, 2025-03-31) — Minority Interests: -200000.00
VREX cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
VREX balance_sheet (quarterly, 2025-03-31) — Net Debt: 362100000.00
VREX income_statement (quarterly, 2025-03-31) — Net Income: 6900000.00
VREX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 6900000.00
VREX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 7100000.00
VREX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 6900000.00
VREX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 6900000.00
VREX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 7100000.00
VREX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 7100000.00
VREX income_statement (quarterly, 2025-03-31) — Net Interest Income: -7300000.00
VREX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 21700000.00
VREX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -400000.00
VREX cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -400000.00
VREX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -7300000.00
VREX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -2000000.00
VREX cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -200000.00
VREX balance_sheet (quarterly, 2025-03-31) — Net PPE: 177600000.00
VREX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -6800000.00
VREX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 244100000.00
VREX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 3000000.00
VREX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 0.00
VREX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 3000000.00
VREX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
VREX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 26800000.00
VREX income_statement (quarterly, 2025-03-31) — Normalized Income: 6900000.00
VREX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 16600000.00
VREX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 1500000.00
VREX income_statement (quarterly, 2025-03-31) — Operating Income: 22100000.00
VREX income_statement (quarterly, 2025-03-31) — Operating Revenue: 212900000.00
VREX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 41512831.00
VREX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 30400000.00
VREX balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 1400000.00
VREX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -2400000.00
VREX income_statement (quarterly, 2025-03-31) — Other Income Expense: -4000000.00
VREX balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 15300000.00
VREX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1200000.00
VREX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 164400000.00
VREX balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 39500000.00
VREX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -4000000.00
VREX balance_sheet (quarterly, 2025-03-31) — Other Properties: 177600000.00
VREX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 17900000.00
VREX balance_sheet (quarterly, 2025-03-31) — Payables: 70800000.00
VREX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 153800000.00
VREX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
VREX income_statement (quarterly, 2025-03-31) — Pretax Income: 10800000.00
VREX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -9200000.00
VREX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -6800000.00
VREX balance_sheet (quarterly, 2025-03-31) — Raw Materials: 225800000.00
VREX balance_sheet (quarterly, 2025-03-31) — Receivables: 145700000.00
VREX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 136200000.00
VREX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 6600000.00
VREX cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -400000.00
VREX income_statement (quarterly, 2025-03-31) — Research And Development: 22000000.00
VREX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 77000000.00
VREX cash_flow (quarterly, 2025-03-31) — Sale Of Business: 0.00
VREX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 30900000.00
VREX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 32600000.00
VREX balance_sheet (quarterly, 2025-03-31) — Share Issued: 41512831.00
VREX income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
VREX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 3800000.00
VREX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 549700000.00
VREX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 244100000.00
VREX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
VREX income_statement (quarterly, 2025-03-31) — Tax Provision: 3700000.00
VREX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.34
VREX balance_sheet (quarterly, 2025-03-31) — Total Assets: 1357600000.00
VREX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1115500000.00
VREX balance_sheet (quarterly, 2025-03-31) — Total Debt: 590700000.00
VREX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 563900000.00
VREX income_statement (quarterly, 2025-03-31) — Total Expenses: 190800000.00
VREX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 793700000.00
VREX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 673800000.00
VREX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 624900000.00
VREX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 22100000.00
VREX income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 800000.00
VREX income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
VREX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
VREX balance_sheet (quarterly, 2025-03-31) — Work In Process: 24600000.00
VREX balance_sheet (quarterly, 2025-03-31) — Working Capital: 515000000.00
VREX income_statement (quarterly, 2025-06-30) — +Operating Expense: 54300000.00
VREX income_statement (quarterly, 2025-06-30) — +Total Revenue: 203000000.00
VREX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 70700000.00
VREX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 137000000.00
VREX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 478400000.00
VREX balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -1400000.00
VREX cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 1000000.00
VREX cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 1000000.00
VREX cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 95300000.00
VREX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 41500000.00
VREX income_statement (quarterly, 2025-06-30) — Basic EPS: -2.15
VREX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 332200000.00
VREX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -6300000.00
VREX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 23300000.00
VREX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 400000.00
VREX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 136400000.00
VREX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 152600000.00
VREX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -201200000.00
VREX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -700000.00
VREX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 7700000.00
VREX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 0.00
VREX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 300000.00
VREX cash_flow (quarterly, 2025-06-30) — Change In Inventory: -16500000.00
VREX cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 4800000.00
VREX cash_flow (quarterly, 2025-06-30) — Change In Payable: 0.00
VREX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 300000.00
VREX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -700000.00
VREX cash_flow (quarterly, 2025-06-30) — Change In Receivables: 8600000.00
VREX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -3500000.00
VREX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 8600000.00
VREX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -194200000.00
VREX balance_sheet (quarterly, 2025-06-30) — Common Stock: 400000.00
VREX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 455300000.00
VREX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 135500000.00
VREX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 86000000.00
VREX balance_sheet (quarterly, 2025-06-30) — Current Assets: 619500000.00
VREX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 3900000.00
VREX balance_sheet (quarterly, 2025-06-30) — Current Debt: 1500000.00
VREX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 5400000.00
VREX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 14600000.00
VREX balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 14600000.00
VREX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 176700000.00
VREX cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -3400000.00
VREX cash_flow (quarterly, 2025-06-30) — Deferred Tax: -3400000.00
VREX cash_flow (quarterly, 2025-06-30) — Depreciation: 5800000.00
VREX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 6800000.00
VREX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 6800000.00
VREX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 41500000.00
VREX income_statement (quarterly, 2025-06-30) — Diluted EPS: -2.15
VREX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -89100000.00
VREX income_statement (quarterly, 2025-06-30) — EBIT: -77900000.00
VREX income_statement (quarterly, 2025-06-30) — EBITDA: -71100000.00
VREX cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -600000.00
VREX cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 500000.00
VREX cash_flow (quarterly, 2025-06-30) — End Cash Position: 138500000.00
VREX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -201200000.00
VREX balance_sheet (quarterly, 2025-06-30) — Finished Goods: 38800000.00
VREX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 1400000.00
VREX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -5400000.00
VREX balance_sheet (quarterly, 2025-06-30) — Goodwill: 198500000.00
VREX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 213500000.00
VREX balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 138400000.00
VREX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 176700000.00
VREX income_statement (quarterly, 2025-06-30) — Gross Profit: 67500000.00
VREX income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 93900000.00
VREX cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 3100000.00
VREX income_statement (quarterly, 2025-06-30) — Interest Expense: 8700000.00
VREX income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 8700000.00
VREX income_statement (quarterly, 2025-06-30) — Interest Income: 2500000.00
VREX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 2500000.00
VREX cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 16700000.00
VREX balance_sheet (quarterly, 2025-06-30) — Inventory: 298700000.00
VREX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 822800000.00
VREX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -700000.00
VREX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 24600000.00
VREX cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
VREX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 19400000.00
VREX balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 366000000.00
VREX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 385400000.00
VREX cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
VREX balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 24600000.00
VREX balance_sheet (quarterly, 2025-06-30) — Minority Interest: 14200000.00
VREX income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
VREX cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
VREX balance_sheet (quarterly, 2025-06-30) — Net Debt: 231100000.00
VREX income_statement (quarterly, 2025-06-30) — Net Income: -89100000.00
VREX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -89100000.00
VREX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -89100000.00
VREX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -89100000.00
VREX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -89100000.00
VREX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -89100000.00
VREX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -89100000.00
VREX income_statement (quarterly, 2025-06-30) — Net Interest Income: -6900000.00
VREX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 4800000.00
VREX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -200400000.00
VREX cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 1100000.00
VREX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -6900000.00
VREX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -800000.00
VREX cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 800000.00
VREX balance_sheet (quarterly, 2025-06-30) — Net PPE: 176700000.00
VREX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -6300000.00
VREX cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -200400000.00
VREX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 241800000.00
VREX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 3000000.00
VREX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 2600000.00
VREX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 3000000.00
VREX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2600000.00
VREX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 22800000.00
VREX income_statement (quarterly, 2025-06-30) — Normalized Income: -14919000.00
VREX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 7700000.00
VREX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -700000.00
VREX income_statement (quarterly, 2025-06-30) — Operating Income: 13200000.00
VREX income_statement (quarterly, 2025-06-30) — Operating Revenue: 203000000.00
VREX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 41520742.00
VREX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 31200000.00
VREX balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 1500000.00
VREX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -5400000.00
VREX income_statement (quarterly, 2025-06-30) — Other Income Expense: -92900000.00
VREX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 15000000.00
VREX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -1400000.00
VREX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 36100000.00
VREX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 39200000.00
VREX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1000000.00
VREX balance_sheet (quarterly, 2025-06-30) — Other Properties: 176700000.00
VREX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 16200000.00
VREX balance_sheet (quarterly, 2025-06-30) — Payables: 70700000.00
VREX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 156700000.00
VREX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
VREX income_statement (quarterly, 2025-06-30) — Pretax Income: -86600000.00
VREX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
VREX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
VREX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -6300000.00
VREX balance_sheet (quarterly, 2025-06-30) — Raw Materials: 231900000.00
VREX balance_sheet (quarterly, 2025-06-30) — Receivables: 137000000.00
VREX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 135500000.00
VREX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 6800000.00
VREX cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -200400000.00
VREX income_statement (quarterly, 2025-06-30) — Research And Development: 21400000.00
VREX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -18100000.00
VREX cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
VREX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 4800000.00
VREX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 32900000.00
VREX balance_sheet (quarterly, 2025-06-30) — Share Issued: 41520742.00
VREX cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -200400000.00
VREX income_statement (quarterly, 2025-06-30) — Special Income Charges: -93900000.00
VREX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 3700000.00
VREX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 455300000.00
VREX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 241800000.00
VREX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -19719000.00
VREX income_statement (quarterly, 2025-06-30) — Tax Provision: 2500000.00
VREX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
VREX balance_sheet (quarterly, 2025-06-30) — Total Assets: 1073400000.00
VREX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 821300000.00
VREX balance_sheet (quarterly, 2025-06-30) — Total Debt: 390800000.00
VREX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 469500000.00
VREX income_statement (quarterly, 2025-06-30) — Total Expenses: 189800000.00
VREX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 603900000.00
VREX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 453900000.00
VREX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 427200000.00
VREX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -80700000.00
VREX income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 700000.00
VREX income_statement (quarterly, 2025-06-30) — Total Unusual Items: -93900000.00
VREX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -93900000.00
VREX balance_sheet (quarterly, 2025-06-30) — Work In Process: 28000000.00
VREX balance_sheet (quarterly, 2025-06-30) — Working Capital: 442800000.00
VREX income_statement (annual, 2025-09-30) — +Operating Expense: 224400000.00
VREX income_statement (quarterly, 2025-09-30) — +Operating Expense: 58200000.00
VREX income_statement (annual, 2025-09-30) — +Total Revenue: 844600000.00
VREX income_statement (quarterly, 2025-09-30) — +Total Revenue: 228900000.00
VREX balance_sheet (annual, 2025-09-30) — Accounts Payable: 69900000.00
VREX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 69900000.00
VREX balance_sheet (annual, 2025-09-30) — Accounts Receivable: 156600000.00
VREX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 156600000.00
VREX balance_sheet (annual, 2025-09-30) — Accumulated Depreciation: -271000000.00
VREX balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -271000000.00
VREX balance_sheet (annual, 2025-09-30) — Additional Paid In Capital: 483300000.00
VREX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 483300000.00
VREX balance_sheet (annual, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -2100000.00
VREX balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -2100000.00
VREX cash_flow (annual, 2025-09-30) — Amortization Cash Flow: 4000000.00
VREX cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 1100000.00
VREX cash_flow (annual, 2025-09-30) — Amortization Of Intangibles: 4000000.00
VREX cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 1100000.00
VREX cash_flow (annual, 2025-09-30) — Asset Impairment Charge: 97700000.00
VREX cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 800000.00
VREX income_statement (annual, 2025-09-30) — Basic Average Shares: 41400000.00
VREX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 41600000.00
VREX income_statement (annual, 2025-09-30) — Basic EPS: -1.70
VREX income_statement (quarterly, 2025-09-30) — Basic EPS: 0.29
VREX cash_flow (annual, 2025-09-30) — Beginning Cash Position: 170400000.00
VREX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 138500000.00
VREX balance_sheet (annual, 2025-09-30) — Buildings And Improvements: 166300000.00
VREX balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 166300000.00
VREX cash_flow (annual, 2025-09-30) — Capital Expenditure: -22900000.00
VREX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -5600000.00
VREX balance_sheet (annual, 2025-09-30) — Capital Lease Obligations: 28400000.00
VREX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 28400000.00
VREX balance_sheet (annual, 2025-09-30) — Capital Stock: 400000.00
VREX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 400000.00
VREX balance_sheet (annual, 2025-09-30) — Cash And Cash Equivalents: 145000000.00
VREX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 145000000.00
VREX balance_sheet (annual, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 155100000.00
VREX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 155100000.00
VREX cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Financing Activities: -75900000.00
VREX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 1100000.00
VREX cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Investing Activities: 10300000.00
VREX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -700000.00
VREX cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Operating Activities: 41700000.00
VREX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 7900000.00
VREX cash_flow (annual, 2025-09-30) — Change In Account Payable: 6200000.00
VREX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -5400000.00
VREX cash_flow (annual, 2025-09-30) — Change In Accrued Expense: 100000.00
VREX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 11500000.00
VREX cash_flow (annual, 2025-09-30) — Change In Inventory: -39900000.00
VREX cash_flow (quarterly, 2025-09-30) — Change In Inventory: -2300000.00
VREX cash_flow (annual, 2025-09-30) — Change In Other Working Capital: 5700000.00
VREX cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -1900000.00
VREX cash_flow (annual, 2025-09-30) — Change In Payable: 6200000.00
VREX cash_flow (quarterly, 2025-09-30) — Change In Payable: -5400000.00
VREX cash_flow (annual, 2025-09-30) — Change In Payables And Accrued Expense: 6300000.00
VREX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 6100000.00
VREX cash_flow (annual, 2025-09-30) — Change In Prepaid Assets: -3600000.00
VREX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 1700000.00
VREX cash_flow (annual, 2025-09-30) — Change In Receivables: 100000.00
VREX cash_flow (quarterly, 2025-09-30) — Change In Receivables: -20100000.00
VREX cash_flow (annual, 2025-09-30) — Change In Working Capital: -31400000.00
VREX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -16500000.00
VREX cash_flow (annual, 2025-09-30) — Changes In Account Receivables: 100000.00
VREX cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -20100000.00
VREX cash_flow (annual, 2025-09-30) — Changes In Cash: -23900000.00
VREX cash_flow (quarterly, 2025-09-30) — Changes In Cash: 8300000.00
VREX balance_sheet (annual, 2025-09-30) — Common Stock: 400000.00
VREX balance_sheet (quarterly, 2025-09-30) — Common Stock: 400000.00
VREX balance_sheet (annual, 2025-09-30) — Common Stock Equity: 472600000.00
VREX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 472600000.00
VREX balance_sheet (annual, 2025-09-30) — Construction In Progress: 36900000.00
VREX balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 36900000.00
VREX income_statement (annual, 2025-09-30) — Cost Of Revenue: 554100000.00
VREX income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 151100000.00
VREX balance_sheet (annual, 2025-09-30) — Current Accrued Expenses: 29700000.00
VREX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 29700000.00
VREX balance_sheet (annual, 2025-09-30) — Current Assets: 641800000.00
VREX balance_sheet (quarterly, 2025-09-30) — Current Assets: 641800000.00
VREX balance_sheet (annual, 2025-09-30) — Current Capital Lease Obligation: 4400000.00
VREX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 4400000.00
VREX balance_sheet (annual, 2025-09-30) — Current Debt: 1500000.00
VREX balance_sheet (quarterly, 2025-09-30) — Current Debt: 1500000.00
VREX balance_sheet (annual, 2025-09-30) — Current Debt And Capital Lease Obligation: 5900000.00
VREX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 5900000.00
VREX balance_sheet (annual, 2025-09-30) — Current Deferred Liabilities: 13000000.00
VREX balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 13000000.00
VREX balance_sheet (annual, 2025-09-30) — Current Deferred Revenue: 13000000.00
VREX balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 13000000.00
VREX balance_sheet (annual, 2025-09-30) — Current Liabilities: 187200000.00
VREX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 187200000.00
VREX cash_flow (annual, 2025-09-30) — Deferred Income Tax: -500000.00
VREX cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 2700000.00
VREX cash_flow (annual, 2025-09-30) — Deferred Tax: -500000.00
VREX cash_flow (quarterly, 2025-09-30) — Deferred Tax: 2700000.00
VREX cash_flow (annual, 2025-09-30) — Depreciation: 23200000.00
VREX cash_flow (quarterly, 2025-09-30) — Depreciation: 5600000.00
VREX cash_flow (annual, 2025-09-30) — Depreciation Amortization Depletion: 27200000.00
VREX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 6700000.00
VREX cash_flow (annual, 2025-09-30) — Depreciation And Amortization: 27200000.00
VREX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 6700000.00
VREX balance_sheet (annual, 2025-09-30) — Derivative Product Liabilities: 0.00
VREX balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 0.00
VREX income_statement (annual, 2025-09-30) — Diluted Average Shares: 41400000.00
VREX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 41800000.00
VREX income_statement (annual, 2025-09-30) — Diluted EPS: -1.70
VREX income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.29
VREX income_statement (annual, 2025-09-30) — Diluted NI Availto Com Stockholders: -70300000.00
VREX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 12200000.00
VREX income_statement (annual, 2025-09-30) — EBIT: -26500000.00
VREX income_statement (quarterly, 2025-09-30) — EBIT: 21600000.00
VREX income_statement (annual, 2025-09-30) — EBITDA: 700000.00
VREX income_statement (quarterly, 2025-09-30) — EBITDA: 28300000.00
VREX income_statement (annual, 2025-09-30) — Earnings From Equity Interest: -2300000.00
VREX cash_flow (annual, 2025-09-30) — Earnings Losses From Equity Investments: 2700000.00
VREX cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 200000.00
VREX cash_flow (annual, 2025-09-30) — Effect Of Exchange Rate Changes: 600000.00
VREX cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 300000.00
VREX balance_sheet (annual, 2025-09-30) — Employee Benefits: 6200000.00
VREX balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 6200000.00
VREX cash_flow (annual, 2025-09-30) — End Cash Position: 147100000.00
VREX cash_flow (quarterly, 2025-09-30) — End Cash Position: 147100000.00
VREX cash_flow (annual, 2025-09-30) — Financing Cash Flow: -75900000.00
VREX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 1100000.00
VREX balance_sheet (annual, 2025-09-30) — Finished Goods: 40000000.00
VREX balance_sheet (quarterly, 2025-09-30) — Finished Goods: 40000000.00
VREX cash_flow (annual, 2025-09-30) — Free Cash Flow: 18800000.00
VREX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 2300000.00
VREX income_statement (annual, 2025-09-30) — Gain On Sale Of Security: -3000000.00
VREX balance_sheet (annual, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -5200000.00
VREX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -5200000.00
VREX balance_sheet (annual, 2025-09-30) — Goodwill: 198400000.00
VREX balance_sheet (quarterly, 2025-09-30) — Goodwill: 198400000.00
VREX balance_sheet (annual, 2025-09-30) — Goodwill And Other Intangible Assets: 212400000.00
VREX balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 212400000.00
VREX balance_sheet (annual, 2025-09-30) — Gross Accounts Receivable: 158700000.00
VREX balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 158700000.00
VREX balance_sheet (annual, 2025-09-30) — Gross PPE: 458200000.00
VREX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 458200000.00
VREX income_statement (annual, 2025-09-30) — Gross Profit: 290500000.00
VREX income_statement (quarterly, 2025-09-30) — Gross Profit: 77800000.00
VREX income_statement (annual, 2025-09-30) — Impairment Of Capital Assets: 93900000.00
VREX income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
VREX cash_flow (annual, 2025-09-30) — Income Tax Paid Supplemental Data: 18600000.00
VREX cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 1500000.00
VREX income_statement (annual, 2025-09-30) — Interest Expense: 32700000.00
VREX income_statement (quarterly, 2025-09-30) — Interest Expense: 7500000.00
VREX income_statement (annual, 2025-09-30) — Interest Expense Non Operating: 32700000.00
VREX income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 7500000.00
VREX income_statement (annual, 2025-09-30) — Interest Income: 8500000.00
VREX income_statement (quarterly, 2025-09-30) — Interest Income: 1000000.00
VREX income_statement (annual, 2025-09-30) — Interest Income Non Operating: 8500000.00
VREX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 1000000.00
VREX cash_flow (annual, 2025-09-30) — Interest Paid Supplemental Data: 31300000.00
VREX cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 700000.00
VREX balance_sheet (annual, 2025-09-30) — Interest Payable: 13500000.00
VREX balance_sheet (quarterly, 2025-09-30) — Interest Payable: 13500000.00
VREX balance_sheet (annual, 2025-09-30) — Inventory: 299400000.00
VREX balance_sheet (quarterly, 2025-09-30) — Inventory: 299400000.00
VREX balance_sheet (annual, 2025-09-30) — Invested Capital: 840100000.00
VREX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 840100000.00
VREX cash_flow (annual, 2025-09-30) — Investing Cash Flow: 10300000.00
VREX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -700000.00
VREX balance_sheet (annual, 2025-09-30) — Investments And Advances: 24500000.00
VREX balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 24500000.00
VREX cash_flow (annual, 2025-09-30) — Issuance Of Debt: 126900000.00
VREX cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
VREX balance_sheet (annual, 2025-09-30) — Land And Improvements: 8600000.00
VREX balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 8600000.00
VREX balance_sheet (annual, 2025-09-30) — Long Term Capital Lease Obligation: 24000000.00
VREX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 24000000.00
VREX balance_sheet (annual, 2025-09-30) — Long Term Debt: 366000000.00
VREX balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 366000000.00
VREX balance_sheet (annual, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 390000000.00
VREX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 390000000.00
VREX cash_flow (annual, 2025-09-30) — Long Term Debt Issuance: 126900000.00
VREX cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
VREX cash_flow (annual, 2025-09-30) — Long Term Debt Payments: -201900000.00
VREX balance_sheet (annual, 2025-09-30) — Long Term Equity Investment: 24500000.00
VREX balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 24500000.00
VREX balance_sheet (annual, 2025-09-30) — Machinery Furniture Equipment: 217000000.00
VREX balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 217000000.00
VREX balance_sheet (annual, 2025-09-30) — Minority Interest: 14000000.00
VREX balance_sheet (quarterly, 2025-09-30) — Minority Interest: 14000000.00
VREX income_statement (annual, 2025-09-30) — Minority Interests: -400000.00
VREX income_statement (quarterly, 2025-09-30) — Minority Interests: 0.00
VREX cash_flow (annual, 2025-09-30) — Net Business Purchase And Sale: 0.00
VREX cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
VREX balance_sheet (annual, 2025-09-30) — Net Debt: 222500000.00
VREX balance_sheet (quarterly, 2025-09-30) — Net Debt: 222500000.00
VREX income_statement (annual, 2025-09-30) — Net Income: -70300000.00
VREX income_statement (quarterly, 2025-09-30) — Net Income: 12200000.00
VREX income_statement (annual, 2025-09-30) — Net Income Common Stockholders: -70300000.00
VREX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 12200000.00
VREX income_statement (annual, 2025-09-30) — Net Income Continuous Operations: -69900000.00
VREX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 12200000.00
VREX income_statement (annual, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -70300000.00
VREX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 12200000.00
VREX income_statement (annual, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -70300000.00
VREX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 12200000.00
VREX cash_flow (annual, 2025-09-30) — Net Income From Continuing Operations: -69900000.00
VREX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 12200000.00
VREX income_statement (annual, 2025-09-30) — Net Income Including Noncontrolling Interests: -69900000.00
VREX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 12200000.00
VREX income_statement (annual, 2025-09-30) — Net Interest Income: -27000000.00
VREX income_statement (quarterly, 2025-09-30) — Net Interest Income: -6900000.00
VREX cash_flow (annual, 2025-09-30) — Net Investment Purchase And Sale: 34000000.00
VREX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 5400000.00
VREX cash_flow (annual, 2025-09-30) — Net Issuance Payments Of Debt: -75000000.00
VREX cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -400000.00
VREX cash_flow (annual, 2025-09-30) — Net Long Term Debt Issuance: -75000000.00